CoBe Labs

Company Overview

Snapshot

Founded in June 2020 by Haddas Herzog Manor and Meir Refael, CoBe Labs operates with 1–10 employees. The company ceased operations in February 2024, signaling a significant shift in its trajectory.

Business overview

CoBe Labs is developing an accessible AI-based solution focused on the early detection and treatment of adolescent mental and behavioral disorders, particularly anxiety. Their core product is CoBe, a confidential AI-based chatbot designed to help teenagers identify and manage anxiety. The solution integrates universal protocols, such as the Diagnostic and Statistical Manual of Mental Disorders, with real-life proven therapy techniques, leveraging teenagers' mobile usage habits within a secure and private environment. The company operates within the Digital Health and Medical Technologies sector, specifically targeting digital therapeutics and mental health.

Strategic signal

CoBe Labs ceased operations in February 2024. This event indicates a complete halt to the company's development and market presence, signaling to investors and innovation teams that the venture is no longer active in the health tech and life sciences sector.

Company Intelligence Q&A

What is CoBe Labs' primary focus?

CoBe Labs focuses on developing an AI-based solution for the early detection and treatment of adolescent mental and behavioral disorders, specifically anxiety.

Who founded CoBe Labs?

CoBe Labs was founded by Haddas Herzog Manor and Meir Refael in June 2020.

What is the core product offered by CoBe Labs?

The core product is CoBe, a confidential AI-based chatbot designed to help teenagers detect mental and behavioral disorders and overcome anxiety.

In which sector does CoBe Labs primarily operate?

CoBe Labs operates primarily in the Health Tech & Life Sciences sector, with a focus on Digital Healthcare and Digital Therapeutics.

What is the current operational status of CoBe Labs?

CoBe Labs ceased to operate in February 2024, and is currently classified as Non-Active.